# Altitude Crest Partners Inc.

> Institutional holdings reported to the SEC as of Q1 2024 on Form 13F. CIK 1986035. Source: https://holderbook.com/funds/1986035-altitude-crest-partners-inc/

- Reported value: $233.6M
- Positions: 30
- Weight of the ten largest: 69.3%
- Filed: 2024-05-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| LEGEND BIOTECH CORP | [LEGN](https://holderbook.com/stocks/LEGN/) | $36.6M | 652,732 | 15.7% | 2 |
| DANAHER CORP DEL | [DHR](https://holderbook.com/stocks/DHR/) | $27.1M | 108,700 | 11.6% | 2 |
| BRIDGEBIO PHARMA INC | [BBIO](https://holderbook.com/stocks/BBIO/) | $18.9M | 612,060 | 8.1% | 2 |
| STEVANATO GROUP S P A | [STVN](https://holderbook.com/stocks/STVN/) | $17.7M | 550,000 | 7.6% | 1 |
| APELLIS PHARMACEUTICALS INC | [APLS](https://holderbook.com/stocks/APLS/) | $16.9M | 287,277 | 7.2% | 2 |
| THERMO FISHER SCIENTIFIC INC | [TMO](https://holderbook.com/stocks/TMO/) | $10.7M | 18,400 | 4.6% | 1 |
| ARRIVENT BIOPHARMA INC | [AVBP](https://holderbook.com/stocks/AVBP/) | $9.9M | 555,555 | 4.2% | 1 |
| STRUCTURE THERAPEUTICS INC | [GPCR](https://holderbook.com/stocks/GPCR/) | $8.8M | 205,166 | 3.8% | 1 |
| KINIKSA PHARMACEUTICALS LTD | [KNSA](https://holderbook.com/stocks/KNSA/) | $7.9M | 400,441 | 3.4% | 2 |
| JANUX THERAPEUTICS INC | [JANX](https://holderbook.com/stocks/JANX/) | $7.3M | 193,300 | 3.1% | 1 |
| ELI LILLY & CO | [LLY](https://holderbook.com/stocks/LLY/) | $7.2M | 9,200 | 3.1% | 1 |
| BIOHAVEN LTD | [BHVN](https://holderbook.com/stocks/BHVN/) | $6.5M | 118,380 | 2.8% | 1 |
| IMMUNOME INC | [IMNM](https://holderbook.com/stocks/IMNM/) | $6.5M | 262,284 | 2.8% | 1 |
| SPRINGWORKS THERAPEUTICS INC | [SWTX](https://holderbook.com/stocks/SWTX/) | $6.3M | 128,842 | 2.7% | 1 |
| GERON CORP | [GERN](https://holderbook.com/stocks/GERN/) | $5.1M | 1,531,400 | 2.2% | 1 |
| ICON PUB LTD CO | [ICLR](https://holderbook.com/stocks/ICLR/) | $5.0M | 14,800 | 2.1% | 1 |
| MERUS N V | [MRUS](https://holderbook.com/stocks/MRUS/) | $4.9M | 109,837 | 2.1% | 1 |
| ROIVANT SCIENCES LTD | [ROIV](https://holderbook.com/stocks/ROIV/) | $4.8M | 454,766 | 2.1% | 2 |
| DENALI THERAPEUTICS INC | [DNLI](https://holderbook.com/stocks/DNLI/) | $4.3M | 209,613 | 1.8% | 1 |
| CORBUS PHARMACEUTICALS HLDGS | [CRBP](https://holderbook.com/stocks/CRBP/) | $4.1M | 103,703 | 1.7% | 1 |
| AGIOS PHARMACEUTICALS INC | [AGIO](https://holderbook.com/stocks/AGIO/) | $3.3M | 113,100 | 1.4% | 1 |
| DAY ONE BIOPHARMACEUTICALS I | [DAWN](https://holderbook.com/stocks/DAWN/) | $3.2M | 195,497 | 1.4% | 1 |
| ALIGOS THERAPEUTICS INC | [ALGS](https://holderbook.com/stocks/ALGS/) | $2.8M | 2,844,681 | 1.2% | 2 |
| ENGENE HOLDINGS INC | [ENGN](https://holderbook.com/stocks/ENGN/) | $2.0M | 120,289 | 0.9% | 1 |
| APPLIED THERAPEUTICS INC | [APLT](https://holderbook.com/stocks/APLT/) | $1.8M | 259,700 | 0.8% | 1 |
| ZYMEWORKS INC | [ZYME](https://holderbook.com/stocks/ZYME/) | $1.5M | 145,581 | 0.7% | 1 |
| METAGENOMI THERAPEUTICS INC | [MGX](https://holderbook.com/stocks/MGX/) | $1.4M | 133,333 | 0.6% | 1 |
| TOURMALINE BIO INC | [TRML](https://holderbook.com/stocks/TRML/) | $1.1M | 47,400 | 0.5% | 1 |
| ALNYLAM PHARMACEUTICALS INC | [ALNY](https://holderbook.com/stocks/ALNY/) | $29.9K | 200 | 0.0% | 1 |
| SURROZEN INC | [SRZNW](https://holderbook.com/stocks/SRZNW/) | $12.5K | 384,573 | 0.0% | 2 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q1 2024 | -4.7% | +10.0% | -14.8% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q1 2024 | $233.6M | 30 |
| Q4 2023 | $149.4M | 12 |